ArticleFrontiers in immunology2025
Long-term survival benefit from third-line treatment for advanced colon cancer: a case report.
Ju Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleFrontiers in immunology2025
Ju Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.